1. Market Research
  2. > Healthcare Market Trends
Global Digital Therapeutics Industry

Global Digital Therapeutics Industry

  • September 2020
  • 205 pages
  • ID: 5798376
  • Format: PDF
  • Global Industry Analysts


Table of Contents


Timely market intelligence is paramount in these uncertain times!

We launched an impact survey to update this project with timely insights during 2020. Update frequency will depend upon evolving market conditions and executive opinions. Our participants are executives driving strategy, marketing, sales and product management at competitive companies worldwide. All updates during the rest of the year are complimentary to clients!

The global market for Digital Therapeutics (DTx) is projected to reach US$1.0 billion by 2025 driven by strong adoption of digital platforms like smartphones, apps, electronic wearables, mobile internet; growing focus on value based care; and rising venture capital investments in digital health based business models. DTx involves the use of online technology platforms such as mHealth tools; medical sensors; electronic medical wearables; artificial intelligence (IT); telehealth & wireless communication platforms; smartphones, apps and mobile internet, to offer medical care. The goal of DTx is to induce behavioral and lifestyle changes that positively influence disease treatment outcomes. Benefits of digital therapeutics driving its importance in the healthcare industry include the promise of overcoming the limitation of current primary care by providing timely and proactive care, reducing the risk of disease progression and lowering the burden on emergency care; enables continuous remote patient monitoring; provides social support and guidance; enables implementation of preventive healthcare; ensures patient empowerment as it encourages treatment plans based on self-reported data like diet and other lifestyle factors; greater accountability of care givers; continued support in between doctor visits; and improved treatment outcome.

Healthcare reforms and the ensuing migration to value based care will provide the Launchpad for increased acceptance, adoption and proliferation of DTx, as the technology has the potential to reduce healthcare costs while simultaneously increase efficiency. Key features that make DTx a natural fit for value based care include cost of DTx which is significantly lower than traditional medicine; patient centric continuum of care; use of outcome oriented and evidence based therapeutic solutions; elimination of wasteful healthcare expenditure as timely care reduces the need for diagnostic and intensive drug interventions; lower consumption of hospital resources as it reduces the pressure on an already overburdened emergence care; better use of patient engagement that encourages self-management of diseases; and use of real-time actionable insights that help optimize care delivery decisions. Digital solutions which are emerging as effective therapy tools include electronic CBT (cognitive behavioral therapy); virtual therapy guidance and counselling that include web therapy, phone therapy, text therapy or online therapy; therapy support applications that educate and offer advice on coping strategies, relaxation techniques, medication reminders and references to nearby treatment programs to ensure accessibility; and telediagnosis/remote diagnostics. Of special note is the hidden and the yet untapped value in the "Medicine as a Service" business model that brings even pharmaceutical companies into the value based care loop. Faced with competition and profitability pressures, drug companies are entering into the DTx space as powerful ecosystem players backed with financial resources to offer services that improve access and adherence to prescription drugs for chronic conditions. Powered by the dynamics of cloud computing "Medicine as a Service" pushes patients into the center of business strategies of drug companies.

As the healthcare community seeks to cost-effectively tackle the growing economic and financial burden of chronic diseases such as diabetes, hypertension and cardiovascular diseases, DTx will emerge as the way forward in healthcare. As the number of people living with diseases increase, healthcare strategies should evolve beyond just the pill to a continuous care plan that include staying informed and engaged. The biggest impact of DTx is in the field of mental health as it offers a novel therapy platform for this hugely unmet medical field. Gamification in mental health apps is the newest mhealth tool for positive behavioral reinforcement and to promote patient engagement. Telepsychiatry using videoconferencing and telemedicine eliminates the stigma associated with psychiatric care by offering patients discreet ways to receive medication management care and timely psychiatric evaluations. The United States and Europe represent large markets worldwide with a combined share of 84.4% of the global market. The United States also ranks as the fastest growing market with a CAGR of 27.8% over the analysis period supported by well-developed digital infrastructure that provides the foundation for DTx. The country also spearheads the global commitment towards value-based care and outcome-based healthcare with robust financial incentives that encourage value-based care and disincentives that penalize and prevent wasteful healthcare spending among hospitals.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Digital Therapeutics Market by Application, Product Type, and Sales Channel : Global Opportunity Analysis and Industry Forecast, 2020–2027

  • $ 4125
  • September 2020
  • 280 pages

Digital Therapeutics Market by Application (Diabetes, Obesity, Cardiovascular Disease (CVD), Central Nervous System (CNS) Disease, Respiratory Disease, Smoking Cessation, Gastrointestinal Disorder (GID), ...

  • APAC
  • World
  • Therapy
  • Healthcare
  • Industry analysis
  • Smartphone Penetration

Consumer Health in Sweden $ 2650 November 2020

Consumer Health in Norway $ 2650 November 2020

Consumer Health in Singapore $ 2650 November 2020

Consumer Health in China $ 2650 November 2020

UAE Healthcare Sector Outlook 2023 $ 2000 November 2020


Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on